Jeffrey Bednarski

Medicine & Life Sciences

1. Double-Stranded DNA Breaks 100%
2. Severe Combined Immunodeficiency 89%
3. DNA Damage 77%
4. B-Lymphocytes 72%
5. Bz-423 69%
6. B-Lymphoid Precursor Cells 66%
7. Ataxia Telangiectasia 63%
8. Lymphocytes 53%
9. Antigen Receptors 51%
10. Immune Reconstitution 50%
11. Transplants 47%
12. 1,2-di-(4-sulfamidophenyl)-4-butylpyrazolidine-3,5-dione 43%
13. Benzodiazepines 42%
14. Primary Immunodeficiency Diseases 41%
15. V(D)J Recombination 40%
16. Alemtuzumab 38%
17. Pediatrics 37%
18. Chronic Granulomatous Disease 37%
19. Hemophagocytic Lymphohistiocytosis 36%
20. Cell Transplantation 36%
21. Interleukin-7 34%
22. Infections 34%
23. DNA Breaks 33%
24. Genes 32%
25. Toxoplasma 31%
26. Hematopoietic Stem Cells 29%
27. Immunoglobulin Light Chain Genes 28%
28. T-Lymphocytes 27%
29. G1 Phase 26%
30. Neonatal Screening 26%
31. Germinal Center 24%
32. Hematopoietic Stem Cell Transplantation 24%
33. Phosphotransferases 24%
34. Pre-B Cell Receptors 23%
35. Laurates 23%
36. Toll-Like Receptor 8 23%
37. Transplantation Conditioning 22%
38. Apoptosis 22%
39. Transcription Factors 22%
40. Polynucleotide 5'-Hydroxyl-Kinase 21%
41. Phosphatidylinositol 4,5-Diphosphate 21%
42. Bone Marrow Failure Disorders 20%
43. Ehrlichiosis 20%
44. C2 Domains 20%
45. Tetraspanins 20%
46. Thiotepa 20%
47. Tissue Donors 20%
48. Gene Rearrangement 20%
49. Exfoliative Dermatitis 19%
50. DNA 19%